At the Advancing Precision Medicine Conference (APM) in Philadelphia, Mark Garner, Director of the Translational Research Segment at Agilent Technologies, participated in a discussion panel alongside Dr. Roddy O'Conner and Dr. Saba Ghassemi from the University of Pennsylvania School of Medicine. Mark highlighted the portfolio of cell analysis solutions that provide researchers with relevant tools to measure living cells, dynamically track them, and model their microenvironments. These next-generation therapies enable the assessment of real-time cell function, phenotype, and fate, ultimately allowing translational researchers and developers to achieve the necessary level of therapeutic potency and safety. Learn more on the Agilent Newsroom: https://bit.ly/41cP4FJ #PrecisionMedicine #CellTherapy #CART
Research I Market Development I Agilent I Harvard Medical School
1 天前Congratulations Mark! I'm sure it was a great awareness session for every participant.